MOVING BEYOND A1C: SENSOR BASED GLUCOSE MONITORING IN 2023 (AS-112)

Saturday, October 28, 2023

12:30 – 13:30 EST

Location: Palais, 520A-F

Target Audience: Endocrinologists, Diabetologists, Internists, Family Physicians, Allied Health Professionals

Chair : AS(s)

Remi Rabasa-Lhoret, MD, PhD (he/him/his)

Endocrinologue
IRCM

Presenter : AS(s)

Stewart B. Harris

CM, MD, MPH, FCFP, FACPM
Western University
Western University
Lisa deMolitor (she/her/hers)

Registered Dietitian
.
CT

Christopher Tran (he/him/his)

Endocrinologist
University of Ottawa
University of Ottawa

Disclosure(s):

Remi Rabasa-Lhoret, MD, PhD: Cystic Fibrosis Canada: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); FFRD: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); JDRF: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordik: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Sanofi-Avantis: Consultant/Advisory Board (Terminated), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated), Speaker/Honoraria (Terminated); Société Francophone du Diabète: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)

Lisa deMolitor: Abbott: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Christopher Tran: No financial relationships to disclose

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

understand and explain the rationale and evidence for recommending and facilitating adoption of sensor-based Continuous Glucose Monitoring (Intermittently Scanned & Real Time) technology in treatment plans; and
interpret successfully ambulatory glucose reports by applying the evidence, with the panelists experience in sensor-based technologies to improve patient care.

This program was co-developed by the Canadian Society of Endocrinology and Metabolism and Abbott Laboratories and was planned to achieve scientific integrity, objectivity, and balance.